nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—head and neck cancer—Graves' disease	0.849	1	CtDrD
Vinblastine—CYP2D6—Methimazole—Graves' disease	0.0213	0.611	CbGbCtD
Vinblastine—CYP3A4—Methimazole—Graves' disease	0.0135	0.389	CbGbCtD
Vinblastine—Neuritis—Methimazole—Graves' disease	0.00525	0.133	CcSEcCtD
Vinblastine—Neuritis—Propylthiouracil—Graves' disease	0.00447	0.113	CcSEcCtD
Vinblastine—TUBD1—eye—Graves' disease	0.00285	0.043	CbGeAlD
Vinblastine—TUBG1—eye—Graves' disease	0.00239	0.0361	CbGeAlD
Vinblastine—Neuropathy peripheral—Methimazole—Graves' disease	0.00215	0.0546	CcSEcCtD
Vinblastine—TUBD1—pituitary gland—Graves' disease	0.00211	0.032	CbGeAlD
Vinblastine—TUBD1—adipose tissue—Graves' disease	0.0021	0.0318	CbGeAlD
Vinblastine—Agranulocytosis—Methimazole—Graves' disease	0.00205	0.0519	CcSEcCtD
Vinblastine—TUBE1—pituitary gland—Graves' disease	0.00198	0.03	CbGeAlD
Vinblastine—TUBE1—adipose tissue—Graves' disease	0.00197	0.0298	CbGeAlD
Vinblastine—TUBB3—connective tissue—Graves' disease	0.00187	0.0283	CbGeAlD
Vinblastine—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00183	0.0464	CcSEcCtD
Vinblastine—TUBD1—thyroid gland—Graves' disease	0.00182	0.0275	CbGeAlD
Vinblastine—TUBG1—pituitary gland—Graves' disease	0.00177	0.0268	CbGeAlD
Vinblastine—TUBG1—adipose tissue—Graves' disease	0.00177	0.0267	CbGeAlD
Vinblastine—Agranulocytosis—Propylthiouracil—Graves' disease	0.00174	0.0442	CcSEcCtD
Vinblastine—Alopecia—Methimazole—Graves' disease	0.00174	0.0441	CcSEcCtD
Vinblastine—NR5A1—pituitary gland—Graves' disease	0.00173	0.0262	CbGeAlD
Vinblastine—TUBE1—thyroid gland—Graves' disease	0.00171	0.0258	CbGeAlD
Vinblastine—Haemoglobin—Propylthiouracil—Graves' disease	0.00168	0.0427	CcSEcCtD
Vinblastine—Haemorrhage—Propylthiouracil—Graves' disease	0.00168	0.0425	CcSEcCtD
Vinblastine—ABCC6—eye—Graves' disease	0.00163	0.0247	CbGeAlD
Vinblastine—ABCC6—connective tissue—Graves' disease	0.00158	0.0238	CbGeAlD
Vinblastine—Vertigo—Methimazole—Graves' disease	0.00154	0.0391	CcSEcCtD
Vinblastine—Leukopenia—Methimazole—Graves' disease	0.00154	0.0389	CcSEcCtD
Vinblastine—TUBG1—thyroid gland—Graves' disease	0.00153	0.0231	CbGeAlD
Vinblastine—Alopecia—Propylthiouracil—Graves' disease	0.00148	0.0375	CcSEcCtD
Vinblastine—TUBB1—adipose tissue—Graves' disease	0.0014	0.0212	CbGeAlD
Vinblastine—TUBA1A—eye—Graves' disease	0.00138	0.0209	CbGeAlD
Vinblastine—Thrombocytopenia—Methimazole—Graves' disease	0.00137	0.0348	CcSEcCtD
Vinblastine—JUN—eye—Graves' disease	0.00137	0.0207	CbGeAlD
Vinblastine—TUBA1A—connective tissue—Graves' disease	0.00133	0.0202	CbGeAlD
Vinblastine—JUN—connective tissue—Graves' disease	0.00132	0.02	CbGeAlD
Vinblastine—Vertigo—Propylthiouracil—Graves' disease	0.00131	0.0332	CcSEcCtD
Vinblastine—Leukopenia—Propylthiouracil—Graves' disease	0.00131	0.0331	CcSEcCtD
Vinblastine—Paraesthesia—Methimazole—Graves' disease	0.00126	0.0319	CcSEcCtD
Vinblastine—ABCC6—adipose tissue—Graves' disease	0.00121	0.0183	CbGeAlD
Vinblastine—TUBB4A—eye—Graves' disease	0.00118	0.0179	CbGeAlD
Vinblastine—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00117	0.0296	CcSEcCtD
Vinblastine—TUBB2B—eye—Graves' disease	0.00114	0.0173	CbGeAlD
Vinblastine—TUBB4A—connective tissue—Graves' disease	0.00114	0.0172	CbGeAlD
Vinblastine—TUBB2B—connective tissue—Graves' disease	0.0011	0.0166	CbGeAlD
Vinblastine—TUBB2A—eye—Graves' disease	0.00108	0.0163	CbGeAlD
Vinblastine—Paraesthesia—Propylthiouracil—Graves' disease	0.00107	0.0271	CcSEcCtD
Vinblastine—ABCC6—thyroid gland—Graves' disease	0.00105	0.0158	CbGeAlD
Vinblastine—TUBB2A—connective tissue—Graves' disease	0.00104	0.0157	CbGeAlD
Vinblastine—TUBA1A—pituitary gland—Graves' disease	0.00103	0.0155	CbGeAlD
Vinblastine—TUBA1A—adipose tissue—Graves' disease	0.00102	0.0155	CbGeAlD
Vinblastine—JUN—pituitary gland—Graves' disease	0.00102	0.0154	CbGeAlD
Vinblastine—JUN—adipose tissue—Graves' disease	0.00101	0.0153	CbGeAlD
Vinblastine—TUBB4B—eye—Graves' disease	0.000922	0.0139	CbGeAlD
Vinblastine—Vomiting—Methimazole—Graves' disease	0.00089	0.0226	CcSEcCtD
Vinblastine—TUBB4B—connective tissue—Graves' disease	0.000888	0.0134	CbGeAlD
Vinblastine—TUBA1A—thyroid gland—Graves' disease	0.000885	0.0134	CbGeAlD
Vinblastine—Headache—Methimazole—Graves' disease	0.000877	0.0222	CcSEcCtD
Vinblastine—JUN—thyroid gland—Graves' disease	0.000877	0.0133	CbGeAlD
Vinblastine—TUBB2B—pituitary gland—Graves' disease	0.000848	0.0128	CbGeAlD
Vinblastine—TUBB2B—adipose tissue—Graves' disease	0.000845	0.0128	CbGeAlD
Vinblastine—Nausea—Methimazole—Graves' disease	0.000831	0.0211	CcSEcCtD
Vinblastine—TUBB—pituitary gland—Graves' disease	0.000802	0.0121	CbGeAlD
Vinblastine—TUBB—adipose tissue—Graves' disease	0.000799	0.0121	CbGeAlD
Vinblastine—TUBB2A—pituitary gland—Graves' disease	0.000798	0.0121	CbGeAlD
Vinblastine—TUBB2A—adipose tissue—Graves' disease	0.000795	0.012	CbGeAlD
Vinblastine—TUBB6—pituitary gland—Graves' disease	0.000787	0.0119	CbGeAlD
Vinblastine—TUBB6—adipose tissue—Graves' disease	0.000784	0.0119	CbGeAlD
Vinblastine—Vomiting—Propylthiouracil—Graves' disease	0.000757	0.0192	CcSEcCtD
Vinblastine—TUBB4A—thyroid gland—Graves' disease	0.000756	0.0114	CbGeAlD
Vinblastine—Headache—Propylthiouracil—Graves' disease	0.000746	0.0189	CcSEcCtD
Vinblastine—TUBB2B—thyroid gland—Graves' disease	0.000731	0.0111	CbGeAlD
Vinblastine—Nausea—Propylthiouracil—Graves' disease	0.000707	0.0179	CcSEcCtD
Vinblastine—TUBB—thyroid gland—Graves' disease	0.000692	0.0105	CbGeAlD
Vinblastine—TUBB2A—thyroid gland—Graves' disease	0.000688	0.0104	CbGeAlD
Vinblastine—TUBB4B—pituitary gland—Graves' disease	0.000684	0.0103	CbGeAlD
Vinblastine—TUBB4B—adipose tissue—Graves' disease	0.000682	0.0103	CbGeAlD
Vinblastine—TUBB6—thyroid gland—Graves' disease	0.000679	0.0103	CbGeAlD
Vinblastine—TUBB4B—thyroid gland—Graves' disease	0.00059	0.00892	CbGeAlD
Vinblastine—ABCC1—pituitary gland—Graves' disease	0.000488	0.00737	CbGeAlD
Vinblastine—ABCC1—adipose tissue—Graves' disease	0.000486	0.00734	CbGeAlD
Vinblastine—ABCC1—thyroid gland—Graves' disease	0.00042	0.00636	CbGeAlD
Vinblastine—TUBB2B—Orphan transporters—GABRA3—Graves' disease	0.000308	0.0303	CbGpPWpGaD
Vinblastine—TUBB6—Orphan transporters—GABRA3—Graves' disease	0.000308	0.0303	CbGpPWpGaD
Vinblastine—TUBB3—Orphan transporters—GABRA3—Graves' disease	0.000298	0.0293	CbGpPWpGaD
Vinblastine—TUBB2A—Orphan transporters—GABRA3—Graves' disease	0.000289	0.0284	CbGpPWpGaD
Vinblastine—TUBB1—Orphan transporters—GABRA3—Graves' disease	0.000282	0.0277	CbGpPWpGaD
Vinblastine—TUBB4A—Orphan transporters—GABRA3—Graves' disease	0.000253	0.0249	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—TNFRSF25—Graves' disease	0.00025	0.0246	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—TNFRSF25—Graves' disease	0.000235	0.0231	CbGpPWpGaD
Vinblastine—TUBB4B—Orphan transporters—GABRA3—Graves' disease	0.000232	0.0228	CbGpPWpGaD
Vinblastine—JUN—CD40/CD40L signaling—CD40—Graves' disease	0.000205	0.0201	CbGpPWpGaD
Vinblastine—ABCB1—pituitary gland—Graves' disease	0.000199	0.00301	CbGeAlD
Vinblastine—ABCB1—adipose tissue—Graves' disease	0.000198	0.003	CbGeAlD
Vinblastine—JUN—TSH signaling pathway—TSHR—Graves' disease	0.000174	0.0171	CbGpPWpGaD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.000173	0.017	CbGpPWpGaD
Vinblastine—ABCB1—thyroid gland—Graves' disease	0.000172	0.00259	CbGeAlD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.000166	0.0163	CbGpPWpGaD
Vinblastine—JUN—IL12 signaling mediated by STAT4—IL2RA—Graves' disease	0.000162	0.0159	CbGpPWpGaD
Vinblastine—TUBA1A—p73 transcription factor network—FAS—Graves' disease	0.00016	0.0158	CbGpPWpGaD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.000155	0.0152	CbGpPWpGaD
Vinblastine—JUN—IL12 signaling mediated by STAT4—HLA-DRB1—Graves' disease	0.000146	0.0144	CbGpPWpGaD
Vinblastine—ABCC6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000136	0.0134	CbGpPWpGaD
Vinblastine—JUN—FAS pathway and Stress induction of HSP regulation—FASLG—Graves' disease	0.000129	0.0127	CbGpPWpGaD
Vinblastine—JUN—FAS pathway and Stress induction of HSP regulation—FAS—Graves' disease	0.000124	0.0122	CbGpPWpGaD
Vinblastine—JUN—IL-2 Signaling Pathway—IL2RA—Graves' disease	0.000123	0.0121	CbGpPWpGaD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000112	0.011	CbGpPWpGaD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.00011	0.0108	CbGpPWpGaD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.000107	0.0106	CbGpPWpGaD
Vinblastine—JUN—IL12 signaling mediated by STAT4—IFNG—Graves' disease	0.000107	0.0105	CbGpPWpGaD
Vinblastine—JUN—IL12 signaling mediated by STAT4—CD4—Graves' disease	0.000103	0.0101	CbGpPWpGaD
Vinblastine—JUN—IL2-mediated signaling events—IL2RA—Graves' disease	0.000101	0.00993	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—CD8A—Graves' disease	9.54e-05	0.00938	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—FASLG—Graves' disease	8.97e-05	0.00882	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	8.89e-05	0.00874	CbGpPWpGaD
Vinblastine—JUN—RANKL/RANK Signaling Pathway—ICAM1—Graves' disease	8.63e-05	0.00849	CbGpPWpGaD
Vinblastine—JUN—IL1-mediated signaling events—IL1B—Graves' disease	8.61e-05	0.00846	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—IL2RA—Graves' disease	8.6e-05	0.00846	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—HLA-A—Graves' disease	8.51e-05	0.00836	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—HLA-A—Graves' disease	8.11e-05	0.00798	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	7.95e-05	0.00781	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—GABRA3—Graves' disease	7.64e-05	0.00751	CbGpPWpGaD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	7.58e-05	0.00745	CbGpPWpGaD
Vinblastine—TUBB6—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.53e-05	0.00741	CbGpPWpGaD
Vinblastine—TUBB2B—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.53e-05	0.00741	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—CD8A—Graves' disease	7.45e-05	0.00732	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—FASLG—Graves' disease	7.4e-05	0.00727	CbGpPWpGaD
Vinblastine—TUBB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.27e-05	0.00715	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—FAS—Graves' disease	7.13e-05	0.00701	CbGpPWpGaD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	7.09e-05	0.00697	CbGpPWpGaD
Vinblastine—TUBB2A—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.04e-05	0.00693	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	6.94e-05	0.00682	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—FASLG—Graves' disease	6.94e-05	0.00682	CbGpPWpGaD
Vinblastine—TUBA1A—Metabolism of proteins—B3GNT2—Graves' disease	6.94e-05	0.00682	CbGpPWpGaD
Vinblastine—TUBB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	6.89e-05	0.00677	CbGpPWpGaD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	6.76e-05	0.00664	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—FAS—Graves' disease	6.75e-05	0.00664	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—FAS—Graves' disease	6.69e-05	0.00658	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Receptor Signaling—IFNG—Graves' disease	6.66e-05	0.00655	CbGpPWpGaD
Vinblastine—JUN—IL2-mediated signaling events—IFNG—Graves' disease	6.66e-05	0.00655	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—ICAM1—Graves' disease	6.27e-05	0.00616	CbGpPWpGaD
Vinblastine—JUN—ATF-2 transcription factor network—IFNG—Graves' disease	6.21e-05	0.0061	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	6.2e-05	0.0061	CbGpPWpGaD
Vinblastine—TUBB4A—Transmembrane transport of small molecules—GABRA3—Graves' disease	6.18e-05	0.00608	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—FASLG—Graves' disease	6.01e-05	0.00591	CbGpPWpGaD
Vinblastine—JUN—IL-1 signaling pathway—IL1B—Graves' disease	5.86e-05	0.00576	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—GABRA3—Graves' disease	5.85e-05	0.00575	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	5.68e-05	0.00558	CbGpPWpGaD
Vinblastine—TUBB4B—Transmembrane transport of small molecules—GABRA3—Graves' disease	5.66e-05	0.00556	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—B3GNT2—Graves' disease	5.58e-05	0.00549	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—B3GNT2—Graves' disease	5.58e-05	0.00549	CbGpPWpGaD
Vinblastine—JUN—Regulation of Telomerase—IFNG—Graves' disease	5.54e-05	0.00545	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—GC—Graves' disease	5.44e-05	0.00535	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—IFNG—Graves' disease	5.41e-05	0.00532	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—B3GNT2—Graves' disease	5.39e-05	0.0053	CbGpPWpGaD
Vinblastine—JUN—TWEAK Signaling Pathway—TNF—Graves' disease	5.27e-05	0.00519	CbGpPWpGaD
Vinblastine—JUN—FAS pathway and Stress induction of HSP regulation—TNF—Graves' disease	5.27e-05	0.00519	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—B3GNT2—Graves' disease	5.22e-05	0.00513	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—B3GNT2—Graves' disease	5.1e-05	0.00502	CbGpPWpGaD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	4.9e-05	0.00482	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	4.77e-05	0.00469	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—FAS—Graves' disease	4.74e-05	0.00466	CbGpPWpGaD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	4.59e-05	0.00451	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—B3GNT2—Graves' disease	4.58e-05	0.0045	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-E—Graves' disease	4.38e-05	0.00431	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Receptor Signaling—TNF—Graves' disease	4.31e-05	0.00424	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—CD40—Graves' disease	4.28e-05	0.00421	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—CD4—Graves' disease	4.28e-05	0.00421	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—FASLG—Graves' disease	4.25e-05	0.00418	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—CTLA4—Graves' disease	4.22e-05	0.00415	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—B3GNT2—Graves' disease	4.19e-05	0.00412	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—FAS—Graves' disease	4.1e-05	0.00403	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—GC—Graves' disease	4.09e-05	0.00402	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—IL1B—Graves' disease	3.95e-05	0.00388	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IFNG—Graves' disease	3.91e-05	0.00385	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	3.83e-05	0.00377	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	3.7e-05	0.00364	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	3.67e-05	0.00361	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—GABRA3—Graves' disease	3.66e-05	0.00359	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—GABRA3—Graves' disease	3.61e-05	0.00355	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	3.57e-05	0.00351	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—FAS—Graves' disease	3.55e-05	0.00349	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IL1B—Graves' disease	3.49e-05	0.00343	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	3.48e-05	0.00342	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	3.15e-05	0.00309	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-B—Graves' disease	3.12e-05	0.00307	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—FASLG—Graves' disease	3.05e-05	0.003	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—TNF—Graves' disease	3.03e-05	0.00298	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—FAS—Graves' disease	2.94e-05	0.00289	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL2RA—Graves' disease	2.93e-05	0.00288	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-A—Graves' disease	2.89e-05	0.00285	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IFIH1—Graves' disease	2.89e-05	0.00284	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—TNF—Graves' disease	2.82e-05	0.00277	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	2.79e-05	0.00274	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	2.64e-05	0.0026	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	2.59e-05	0.00255	CbGpPWpGaD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	2.56e-05	0.00251	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL1B—Graves' disease	2.54e-05	0.0025	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GC—Graves' disease	2.42e-05	0.00238	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—IL1B—Graves' disease	2.4e-05	0.00236	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HLA-E—Graves' disease	2.27e-05	0.00224	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—TNF—Graves' disease	2.24e-05	0.0022	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	2.02e-05	0.00199	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IFNG—Graves' disease	1.93e-05	0.0019	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—TNF—Graves' disease	1.85e-05	0.00181	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—B3GNT2—Graves' disease	1.84e-05	0.00181	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GC—Graves' disease	1.82e-05	0.00179	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TNF—Graves' disease	1.74e-05	0.00171	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL1B—Graves' disease	1.72e-05	0.00169	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	1.72e-05	0.00169	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFIH1—Graves' disease	1.68e-05	0.00166	CbGpPWpGaD
Vinblastine—ABCC1—Disease—B3GNT2—Graves' disease	1.65e-05	0.00162	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HLA-B—Graves' disease	1.62e-05	0.00159	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GC—Graves' disease	1.59e-05	0.00156	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	1.57e-05	0.00154	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	1.51e-05	0.00148	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	1.45e-05	0.00143	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—B3GNT2—Graves' disease	1.38e-05	0.00136	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-E—Graves' disease	1.32e-05	0.0013	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD40—Graves' disease	1.29e-05	0.00127	CbGpPWpGaD
Vinblastine—JUN—Immune System—CTLA4—Graves' disease	1.28e-05	0.00125	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—TNF—Graves' disease	1.25e-05	0.00123	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—B3GNT2—Graves' disease	1.2e-05	0.00118	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TSHR—Graves' disease	1.16e-05	0.00114	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-DQB1—Graves' disease	1.05e-05	0.00103	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD8A—Graves' disease	9.81e-06	0.000965	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CD4—Graves' disease	9.67e-06	0.000951	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-B—Graves' disease	9.44e-06	0.000928	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL2RA—Graves' disease	8.84e-06	0.000869	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-A—Graves' disease	8.74e-06	0.00086	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GC—Graves' disease	8.66e-06	0.000851	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GC—Graves' disease	8.16e-06	0.000802	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-DRB1—Graves' disease	7.99e-06	0.000785	CbGpPWpGaD
Vinblastine—JUN—Immune System—ICAM1—Graves' disease	7.67e-06	0.000754	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CXCL10—Graves' disease	7.48e-06	0.000735	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HLA-A—Graves' disease	6.67e-06	0.000655	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—B3GNT2—Graves' disease	6.56e-06	0.000645	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—B3GNT2—Graves' disease	6.18e-06	0.000608	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	6.17e-06	0.000606	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFNG—Graves' disease	5.83e-06	0.000574	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2RA—Graves' disease	5.72e-06	0.000562	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD4—Graves' disease	5.63e-06	0.000554	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GC—Graves' disease	5.34e-06	0.000525	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL1B—Graves' disease	5.2e-06	0.000512	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CD4—Graves' disease	4.3e-06	0.000422	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—B3GNT2—Graves' disease	4.04e-06	0.000398	CbGpPWpGaD
